Archive — US — techcrunch
Mark Cuban’s war on America’s $5 trillion healthcare machine: ‘They can’t reactas quickly’
Mark Cuban believes the $5 trillion U.S. healthcare system is flawed due to opaque drug pricing set by pharmacy benefit managers (PBMs). He launched Cost Plus Drugs to provide transparent pricing and challenge the industry's conventional practices. By manufacturing drugs himself and refusing to engage with PBMs, Cuban aims to lower costs and improve access for consumers.
Key points
- Mark Cuban criticizes the U.S. healthcare model for its obscured pricing.
- Cuban identifies pharmacy benefit managers (PBMs) as central to high drug costs.
- He founded Cost Plus Drugs to offer transparent pricing based on cost plus a small markup.
- Generic drugs can be significantly cheaper through his platform compared to traditional pharmacies.
- Cuban's factory in Dallas uses robotics to expedite drug manufacturing and address shortages.
- He advocates for healthcare businesses to operate independently from PBMs to succeed.
Why it matters
- Cuban's approach connects to the ongoing discussions about healthcare reform in the U.S.
- The visibility of drug pricing echoes trends towards transparency in consumer pricing across various sectors.
- Cuban's factory model highlights advancements in healthcare technology and robotics, relevant to the 2025 IT Trends.
Cuban's disruption of the healthcare industry through Cost Plus Drugs challenges established pricing models, fostering transparency and potentially transforming patient access to affordable medications.